EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC 4.0

Therapeutic Potential of Buprenorphine in Depression: A Meta-Analysis of Current Evidence

Siddhi Bhivandkar, Zouina Sarfraz, Lakshit Jain, Anil Bachu, Palash Kumar Malo, Michael Hsu, Shahana Ayub, Laxmi Poudel, Harendra Kumar, Hanyou Loh, Faria Tazin, Saeed Ahmed und 1 weitere

Journal of Clinical Medicine Research · 2024-03 · 16 (2-3) · 46-55

DOI: 10.14740/jocmr5050 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Clinical Medicine Research, 2024-03. Verfasst von Siddhi Bhivandkar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Boston University Medical Center/Boston University School of Medicine, Boston, MA, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Emerging research indicates buprenorphine, used in management of opioid use disorder, has attracted interest for its potential in treating a variety of psychiatric conditions. This meta-analysis aimed to determine the efficacy of buprenorphine in treating symptoms of depression.

Methods

Using Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines, a search was conducted of several databases until April 25, 2022, for English language articles related to buprenorphine and its use in treating various mental health conditions. Standardized mean differences (SMDs) and its 95% confidence intervals (CIs) were reported for the Hamilton Rating Scale for Depression (HAM-D) and the Montgomery-Asberg Depression Rating Scale (MADRS) scores. Statistical analyses were performed using Cochrane RevMan 5.

Results

Of the 1,347 identified studies, six clinical trials were included. MADRS-10 least square mean difference (LSMD) inter-group assessment favored buprenorphine over placebo, but it lacked statistical significance. Similarly, MADRS scores as well as HAM-D inter-group assessment were in favor of buprenorphine, however, were not statistically significant. These findings suggest a potential therapeutic role for buprenorphine in treating depression, albeit with caution due to the observed lack of statistical significance and the potential for confounding factors.

Conclusions

Preliminary evidence suggests potential efficacy of buprenorphine at lower doses in improving improving outcomes specifically related to depression. However, due to limitations in statistical significance and possible confounding factors, entail cautious interpretation. Further rigorous research is needed to investigate the long-term effects, optimal dosing, and determine the role of adjuvant drug therapy.

Schlagwörter

Stichwörter der Autor:innen

AntidepressantBuprenorphineBuprenorphine-based treatmentBuprenorphine/naloxoneDepressionMajor depressive disorderTreatment-resistant depression

Autor:innen und Institutionen

  • Department of Psychiatry, Boston University Medical Center/Boston University School of Medicine, Boston, MA, USA.
  • Department of Psychiatry, Fatima Jinnah Medical University, Lahore, Pakistan.
  • Department of Psychiatry, Connecticut Valley Hospital, Middletown, CT, USA.
  • Department of Psychiatry, Baptist Health - UAMS Psychiatry Residency Program, North Little Rock, AR, USA.
  • Department of Psychiatry, Centre for Brain Research, Indian Institute of Science, Bengaluru, India.
  • Department of Psychiatry, Emory University School of Medicine, Atlanta, GA, USA.

Zitieren

APA

Bhivandkar, S., Sarfraz, Z., Jain, L., Bachu, A., Malo, P. K., Hsu, M., Ayub, S., Poudel, L., Kumar, H., Loh, H., Tazin, F., Ahmed, S., & Suzuki, J. (2024). Therapeutic Potential of Buprenorphine in Depression: A Meta-Analysis of Current Evidence. Journal of Clinical Medicine Research, 16(2-3), 46-55. https://doi.org/10.14740/jocmr5050

Vancouver

Bhivandkar S, Sarfraz Z, Jain L, Bachu A, Malo PK, Hsu M, et al. Therapeutic Potential of Buprenorphine in Depression: A Meta-Analysis of Current Evidence. Journal of Clinical Medicine Research. 2024;16(2-3):46-55. doi:10.14740/jocmr5050

BibTeX
@article{Bhivandkar2024,
  author = {Bhivandkar, Siddhi and Sarfraz, Zouina and Jain, Lakshit and Bachu, Anil and Malo, Palash Kumar and Hsu, Michael and Ayub, Shahana and Poudel, Laxmi and Kumar, Harendra and Loh, Hanyou and Tazin, Faria and Ahmed, Saeed and Suzuki, Joji},
  title = {Therapeutic Potential of Buprenorphine in Depression: A Meta-Analysis of Current Evidence},
  journal = {Journal of Clinical Medicine Research},
  year = {2024},
  volume = {16},
  number = {2-3},
  pages = {46--55},
  doi = {10.14740/jocmr5050}
}
Kostenlos starten →